The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9227969, 83 ID: ALA3936107
Chembl Id: CHEMBL3936107
PubChem CID: 117876735
Max Phase: Preclinical
Molecular Formula: C29H26F2N6O3
Molecular Weight: 544.56
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccnc(Oc2ccc(-c3cc4c(cc3F)ncc3ncn(C5(C)CCN(C(=O)CO)CC5)c34)c(F)c2)n1
Standard InChI: InChI=1S/C29H26F2N6O3/c1-17-5-8-32-28(35-17)40-18-3-4-19(22(30)11-18)20-12-21-24(13-23(20)31)33-14-25-27(21)37(16-34-25)29(2)6-9-36(10-7-29)26(39)15-38/h3-5,8,11-14,16,38H,6-7,9-10,15H2,1-2H3
Standard InChI Key: GTCQTDKQZUQUNF-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.56Molecular Weight (Monoisotopic): 544.2034AlogP: 4.75#Rotatable Bonds: 5Polar Surface Area: 106.26Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.63CX Basic pKa: 3.22CX LogP: 2.68CX LogD: 2.68Aromatic Rings: 5Heavy Atoms: 40QED Weighted: 0.34Np Likeness Score: -0.81
References 1. (2016) Compounds and compositions as inhibitors of MEK,